AstraZeneca Trial For Breast Cancer Treatment Shows Positive Results
February 17 2017 - 2:45AM
Dow Jones News
By Rory Gallivan
LONDON--AstraZeneca PLC (AZN.LN) Friday announced positive
results from a Phase III trial of its breast cancer treatment
Lynparza.
Metastatic breast cancer patients treated with the drug "showed
a statistically-significant and clinically-meaningful improvement"
compared with patients who received chemotherapy, AstraZeneca
said.
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter:
@RoryGallivan
(END) Dow Jones Newswires
February 17, 2017 02:30 ET (07:30 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024
